August 16, 2020

Easing the Financial Strain from COVID-19: 5 Ways Hospitals and Healthcare Organizations Can Overcome Their Biggest Transaction Management Challenges [Guide]

Even in the best of times, healthcare is a complex, challenging industry. When you add a global pandemic to the picture, the economic strain is immense. To survive today’s challenges and get on a path toward growth, many hospitals and healthcare organizations are exploring financing, M&A, and other initiatives. But how can you balance new transactions on top of your day-to-day operational challenges? Our new report, “Easing the Financial Strain From COVID-19,” reviews how you can overcome today’s biggest transaction management challenges.

Based on research from more than 600 healthcare and corporate development professionals, this guide covers topics such as:

  • The importance of preparing early for strategic transactions
  • Managing disclosures while keeping compliant with HIPAA, PII, and other regulations
  • Strategies to mitigate legal and knowledge loss risks

Take proactive steps to ease the burden on your hospital leadership teams.  

Download your copy of the guide now.

 

  • Easing the Financial Strain from COVID-19

    5 Ways Hospitals and Healthcare Organizations Can Overcome Their Biggest Transaction Management Challenges

  • Restructuring Resource Hub

    We spoke to experts from across different sectors to find out how companies are responding to the economic downturn and evaluting strategic alternatives, whether it be restructuring, refinancing or other opportunities.

Ready to Get Started?

You may also like:

Deal Drivers: APAC Q1 2022

M&A activity across the APAC region as a whole slipped in Q1, which was to be expected after a record-setting 2021. It’s a trend that can be observed across geographic markets an is best understood as a reversion to the mean rather than a cause for concern at this stage. Learn more from our latest Deal Drivers report.

Deal Drivers: EMEA Q1 2022

After a stellar 2021, M&A markets around the world experienced a return to levels more in line with historic precedent in Q1 2022. EMEA was no exception, with deal values and volumes declining. But bright spots persisted. Find out how EMEA M&A performed in Q1 2022 and what lies ahead for the region.

Deal Drivers: Americas Q1 2022 Report

After the ferocious momentum of 2021, dealmaking in the Americas has been easing down in recent months. Not so much a decline as a return to business as usual, the first quarter of 2022 offers clearer indications of what lies ahead.